PTX
Click for more information
1.30% 3.9¢ prescient therapeutics limited

Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-3

  1. Shellbell
    7,765 Posts.
    lightbulb Created with Sketch. 3305
    clock Created with Sketch.
    09/03/23
    09:28
    Post #: 66670396
    Well, this bodes well for a mixed-label pivotal study. I wonder whether our application for ODD in Europe will be amended to include CTCL. At least now, the team won't have to make the difficult decision as to which TCL gets dropped from further study. This is great news! smile.png
    PTX Price at posting: 9.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 48  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
0.001(1.30%) 		Mkt cap ! $31.40M
Open High Low Value Volume
3.9¢ 3.9¢ 3.7¢ $23.65K 615.0K

Buyers (Bids)

No. Vol. Price($)
3 564695 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 26186 2
View Market Depth
Last trade - 15.59pm 03/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.